Interim Results Of A Phase I Study Of M701, A Recombinant Anti-Epcam And Anti-Cd3 Bispecific Antibody In Epcam-Positive Cancer Patients With Malignant AscitesJ. Xu, C. Zhao, Y. Jia,S. Wang,X. Ma, T. Wang, S. Huang, M. Pei, X. Wang, P. ZhouANNALS OF ONCOLOGY（2021）引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
